Eli Lilly rides the weight-loss drug boom Date Tuesday, October 01, 2024 - 10:00 PM Description The company is set to become the first $1tn drugmaker, but investors see warning signs it has reached ‘peak enthusiasm’
Eli Lilly says diabetes and obesity drugs will boost sales by 20% this year Image Date Monday, February 05, 2024 - 11:02 PM
Eli Lilly shares fall after revenue miss for blockbuster weight-loss drugs Date Tuesday, January 14, 2025 - 9:02 AM Description Sales figures for Mounjaro and Zepbound spook investors in world’s biggest drugmaker
Eli Lilly shares surge after study shows weight-loss drug cuts diabetes risk Date Tuesday, August 20, 2024 - 10:24 AM
Eli Lilly to buy cancer specialist Point for $1.4bn Date Tuesday, October 03, 2023 - 10:08 AM Description Point is developing radioligand molecules that can deliver targeted radiation to tumour cells
Eli Lilly told UK health secretary that new drug had ‘potential to prevent Alzheimer’s’ Date Saturday, October 12, 2024 - 10:00 PM Description Drug company made claims even though a study of donanemab’s preventive potential is not due to end until 2027
Eli Lilly: Point acquisition gives battered biotech sector a boost Date Tuesday, October 03, 2023 - 11:41 AM Description Cheaper valuations have finally drawn back cash-rich pharmaceutical makers
Eli Lilly’s weight-loss drug set for UK launch ‘within weeks’ Date Thursday, January 25, 2024 - 1:12 PM Description Mounjaro has achieved 22.5 per cent loss of body weight in trials
Elif Shafak on why Turkey’s youth-led protests offer hope Date Friday, April 04, 2025 - 10:00 PM Description A new generation is finding brilliant and creative ways to object to the arrest of mayor Ekrem İmamoğlu
Elite lawyer indicted in Chile on charges including fraud and bribery Date Tuesday, August 27, 2024 - 11:44 AM Description Probe of Luis Hermosilla, who advised ministers and business leaders, has already ensnared several officials